34
https://pubmed.ncbi.nlm.nih.gov/38115121
PSMA-based prostate cancer therapy and imaging research has significantly increased in the past 20 years, with the United States and Germany being the major contributors, and Australia has recently become very active, and future research is expected to focus on early detection of pelvic lymph nodes and multimodal imaging-guided surgery.